Fulcrum Therapeutics
FULC
#8182
Rank
$0.17 B
Marketcap
$3.20
Share price
7.56%
Change (1 day)
-27.22%
Change (1 year)

EPS for Fulcrum Therapeutics (FULC)

EPS in 2023 (TTM): -$1.80

According to Fulcrum Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.80. In 2022 the company made an earnings per share (EPS) of -$2.48 a decrease over its 2021 EPS that were of -$2.29.

EPS history for Fulcrum Therapeutics from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.80-27.42%
2022-$2.488.3%
2021-$2.29-18.51%
2020-$2.81-31.36%
2019-$4.0977.16%
2018-$2.31

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.18 21.11%๐Ÿ‡บ๐Ÿ‡ธ USA